The Immunity Paradox: Why Isolated Tribes Can Be Devastated by Modern Diseases

Blurs.co.uk
16 Min Read
Summarize with AI

Imagine living in a community where generations of your ancestors have lived largely apart from the outside world. Your community has its own food systems, traditions, knowledge and relationship with nature. Many infectious diseases that circulate routinely through modern cities have never reached your settlement. Then somebody arrives carrying an ordinary respiratory infection. Within weeks, the consequences can be devastating.

Throughout history, isolated indigenous populations have suffered catastrophic losses following contact with diseases that were already commonplace elsewhere. The reason is not that their immune systems are inherently inferior. It is that immunity is shaped, in part, by biological experience: the immune system learns to recognise particular threats, while a population’s collective immunity can influence how far an infection spreads.

This offers a compelling way into the science of herd immunity. It also raises a difficult question: how can societies build population-level protection without paying the terrible price of uncontrolled infection?

The immune system learns from experience

The immune system is not a static defence mechanism. It is a complex network that identifies and responds to potential threats. Its innate arm provides rapid, broad protection through barriers such as skin and mucus membranes, immune cells and chemical responses.

The adaptive immune system is more specialised. B cells can produce antibodies, while T cells help coordinate immune responses and destroy infected cells. Following some infections or vaccinations, a proportion of these cells become long-lived memory cells. If a sufficiently similar pathogen appears again, the immune system may respond more quickly and effectively.

This is immunological memory. It is not universal or permanent: different pathogens produce different patterns of protection, and immunity can wane or be evaded by evolving variants. Exposure does not guarantee lasting immunity, and some infections can cause severe or lasting harm.

The danger of unfamiliar pathogens

The history of contact between outsiders and indigenous communities in the Americas provides stark examples of what can happen when infectious diseases enter populations with little previous exposure. Smallpox, measles and influenza contributed to devastating epidemics following European colonisation. The consequences were shaped not only by biology but also by violence, displacement, malnutrition, enslavement and the disruption of communities.

A 2015 study in Scientific Reports examined 117 contact-related epidemics affecting 59 indigenous societies across Greater Amazonia between 1875 and 2008. It documented more than 11,000 deaths in the recorded outbreaks; measles, influenza and malaria were prominent causes. The research illustrates the vulnerability of small, isolated populations when introduced infections spread through communities with limited prior exposure.

The phrase “virgin-soil epidemic” is sometimes used for an outbreak in a population with little or no previous experience of a particular infection. It does not mean that indigenous people have weaker immune systems. It describes a difference in exposure history and population-level immunity. These communities may have extensive knowledge of, and biological experience with, other local infectious challenges.

What herd immunity means

Herd immunity, also called population immunity, occurs when enough people in a population are immune to an infection that transmission becomes substantially harder to sustain. An infected person is then more likely to encounter people who are protected, interrupting chains of transmission and reducing the chance that the infection reaches someone susceptible.

This indirect protection matters for newborn babies who are too young for certain vaccines, people with particular immune conditions, older people at greater risk from some infections, and those who cannot receive a specific vaccine or do not develop a strong response to it. Herd immunity is therefore not just about individual protection; it can reduce exposure risk across a community.

The effect depends on the disease and on the kind of immunity people have. Protection against severe illness is not necessarily the same as protection against infection or onward transmission. Population immunity can reduce spread without guaranteeing that transmission stops altogether.

The mathematics behind the threshold

Epidemiologists use the basic reproduction number, R₀, to describe the average number of secondary infections caused by one infected person in a fully susceptible population under specified conditions. In a simplified, evenly mixed population with durable, transmission-blocking immunity, the theoretical herd-immunity threshold is often written as H = 1 − (1/R₀).

For a pathogen with an R₀ of 5, the calculation gives 80%. This is an illustration, not a universal target. Real populations are not evenly mixed, and transmission is affected by age, geography, contact patterns, behaviour, immunity strength, waning protection and pathogen evolution. If immunity mainly prevents severe disease but does not prevent infection, the calculation cannot be treated as a reliable threshold for stopping spread.

COVID-19: a modern lesson in population immunity

When SARS-CoV-2 emerged, almost nobody had specific pre-existing immunity to this new virus. It spread through highly connected populations, causing widespread illness and placing enormous pressure on health services. Governments used measures such as ventilation advice, distancing, temporary restrictions and testing to reduce transmission while vaccines were developed.

Infection did produce immune responses involving antibodies, B cells and T cells. But the protection varied between people and over time, and reinfections occurred. The fact that infection could generate immune memory did not make infection harmless: COVID-19 caused deaths, hospitalisations and, for some people, prolonged symptoms and complications.

Vaccines offered a way to train the immune system without requiring people to experience the disease first. COVID-19 vaccines substantially reduced the risk of severe disease, especially during the earlier phases of the pandemic and among people at greatest risk. They also reduced infection and transmission to varying degrees, but that effect was less durable and was affected by new variants.

As SARS-CoV-2 evolved, variants such as Omicron were better able to infect people with some existing immunity. This complicated the idea of reaching a permanent herd-immunity threshold. Researchers increasingly discussed hybrid immunity: immune protection shaped by both vaccination and previous infection. The pandemic showed that population immunity is an evolving relationship between people and a changing pathogen, not a permanent finish line.

Measles shows the value of high population coverage

Measles is one of the clearest examples of why population immunity matters. It is exceptionally contagious, and public-health authorities generally aim for at least 95% two-dose vaccination coverage to prevent sustained transmission. When coverage falls, the virus can find enough susceptible people to spread and outbreaks can occur.

High vaccination coverage protects vaccinated people and also helps shield those who are too young to be vaccinated or cannot receive a vaccine for medical reasons. This is a practical example of collective protection working alongside individual protection.

Smallpox: collective protection on a global scale

The eradication of smallpox demonstrates what coordinated population-level protection can achieve. Through vaccination, surveillance, rapid identification of cases and containment, the global eradication programme interrupted transmission until naturally occurring smallpox was eliminated. It was not vaccination alone in isolation: it was a coordinated public-health effort that combined immunity with case finding and outbreak control.

Does natural infection have benefits?

There is a valid biological point at the centre of this debate: natural infection can produce immune memory. In some diseases, infection may generate broad or durable responses. But the benefit of having immunity must be weighed against the risks of acquiring it through illness. Those risks can include severe disease, complications, long-term effects and death.

The comparison is not simply “natural” versus “artificial”. It is a comparison between the protection an exposure may produce and the harm involved in obtaining it. Vaccination is designed to stimulate protective immunity while avoiding the full risks of the disease. For many infections, that makes vaccination the safer route to individual and population protection.

The best strategy depends on the pathogen, the vaccine, the population and the outcomes being measured. Some vaccines strongly prevent infection and transmission; others are especially valuable because they reduce severe disease. Public-health policy should be based on evidence about those differences, not on a blanket claim that either natural infection or vaccination always produces the same result.

Does modern life make us immunologically weaker?

It is tempting to conclude that better sanitation and fewer infections leave modern populations less capable of defending themselves. That is too broad. People do not need to catch dangerous diseases to develop a functioning immune system. Clean water, sanitation, nutrition and vaccination have prevented enormous amounts of illness and premature death.

A population can nevertheless be vulnerable to a new pathogen if few people have specific pre-existing immunity to it. COVID-19 demonstrated this clearly. That vulnerability was not proof that modern medicine had weakened the immune system; it reflected the arrival of a new virus in a largely susceptible population.

The hygiene hypothesis is a separate and complex area of research. It explores whether changes in early-life exposure to certain microorganisms may influence immune regulation and conditions such as allergies. It is not evidence that children should be deliberately exposed to dangerous infections.

The uncomfortable lesson from isolated populations

No human population is universally protected against every infectious threat. Each community has its own history of exposure, immunity and disease. A population with substantial immunity to one group of pathogens may have little protection against another. An isolated Amazonian community encountering measles and the global population encountering a new coronavirus are very different situations, but both illustrate the importance of pathogen-specific immunity.

Individual immune histories combine to shape how infections move through a population. That is the central insight behind herd immunity: immunity can have benefits beyond the person who possesses it. It can interrupt transmission chains and reduce the risks faced by people who remain susceptible.

Frequently asked questions

Can someone have a healthy immune system and still catch a new disease?

Yes. A healthy immune system does not automatically recognise every pathogen. Innate immunity provides broad protection, while the adaptive immune system may need to develop a specific response to an unfamiliar infection.

Why can isolated communities be more vulnerable to introduced diseases?

If a community has had little previous exposure to a pathogen, fewer people may have specific immune memory. In a small population, an introduced infection can spread rapidly, with devastating consequences. Social disruption, poor access to healthcare and other conditions can make outbreaks worse.

Does catching an infection make the immune system stronger?

Some infections create immunological memory, but they can also cause serious harm. There is no general health benefit to deliberately acquiring dangerous infections. Vaccination can often build protection with much less risk.

Can herd immunity protect people who have not been vaccinated?

Yes. If enough people are immune in ways that reduce transmission, unvaccinated people may receive indirect protection. The degree of protection depends on the disease, vaccine performance, contact patterns and how immunity changes over time.

Why did COVID-19 vaccines not completely stop transmission?

Protection against infection and onward transmission was partial and waned over time. The virus also evolved, and some variants could partially evade existing immune responses. Protection against severe disease was generally more sustained than protection against infection.

Can natural immunity be stronger than vaccine-induced immunity?

It depends on the infection, vaccine, individual and outcome being measured. Infection can generate broad immune responses, but it carries the risks of the disease. Vaccination can provide substantial protection without requiring someone to become ill.

Is herd immunity permanent?

Not necessarily. Immunity can wane, pathogens can evolve, and new susceptible people are born or move into a population. Maintaining protection may require ongoing vaccination, surveillance and other public-health measures.

Why is measles vaccination coverage so important?

Measles is exceptionally contagious. Public-health programmes generally aim for at least 95% two-dose coverage to prevent sustained transmission. Falling coverage leaves openings for outbreaks and puts vulnerable people at risk.

Conclusion: immunity is personal and collective

The history of isolated indigenous populations shows the consequences that can follow when an unfamiliar infection enters a community with little previous immunity. COVID-19 showed that even technologically advanced societies remain vulnerable when a new pathogen emerges. Both examples reinforce the importance of immunological memory and population-level protection.

Herd immunity can reduce transmission, protect vulnerable people and help prevent outbreaks from becoming widespread epidemics. But recognising its benefits is not an argument for uncontrolled exposure. The objective is to build and maintain effective immunity through the safest available means. Modern medicine and the human immune system are not opposing forces; used wisely, they work together.

Sources and further reading

Walker, R.S., Sattenspiel, L. & Hill, K.R. (2015). “Mortality from contact-related epidemics among indigenous populations in Greater Amazonia.” Scientific Reports. https://doi.org/10.1038/srep14032

Omer, S.B., Yildirim, I. & Forman, H.P. (2020). “Herd Immunity and Implications for SARS-CoV-2 Control.” JAMA. https://doi.org/10.1001/jama.2020.20892

Goldblatt, D. (2022). “SARS-CoV-2: from herd immunity to hybrid immunity.” Nature Reviews Immunology. https://doi.org/10.1038/s41577-022-00725-6

World Health Organization. “Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19.” https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-COVID-19

World Health Organization. “Measles.” https://www.who.int/news-room/fact-sheets/detail/measles

World Health Organization. “Smallpox.” https://www.who.int/health-topics/smallpox

Share This Article
Leave a Comment

Leave a Reply